CQR Course Categories
Nuclear Medicine CQR Courses
CQR credit values for a course may not be the same as the biennial credit values for that same course. This section lists the credit values for CQR; however, your transcript and certificate will reflect CE credit values. This will not cause any issues upon submission to the ARRT. The 30 credit cap for a membership to eRADIMAGING is based on be/triennial CE credit values. You are responsible for tracking credits earned toward CQR. You may renew whenever you need to earn more credits.
| COURSE TITLE | SUBCATEGORY | CQR CREDITS | |
|---|---|---|---|
| Back to Basics: Radiography of the Upper Extremities | Other Imaging Procedures | 1.00 | 12/1/2024 |
| Human Trafficking: Identification, Assessment, and Patient Management in the Healthcare Setting | Patient Interactions and Management | 1.25 | 12/1/2024 |
| Positron Emission Mammography | Endocrine and Oncology Procedures | 0.75 | 11/1/2024 |
| The Role of Nuclear Imaging in Gastrointestinal Disorders: GI Cancers | Endocrine and Oncology Procedures | 1.00 | 9/1/2024 |
| The Role of Nuclear Imaging in Gastrointestinal Disorders: GI Cancers | Gastrointestinal and Genitourinary Procedures | 2.00 | 9/1/2024 |
| Breast Cancer Screening: Resolving the Differences in Benefits and Harms | Endocrine and Oncology Procedures | 0.50 | 8/1/2024 |
| Breast Cancer Screening: Resolving the Differences in Benefits and Harms | Patient Interactions and Management | 1.00 | 8/1/2024 |
| The Radiology Technologist and Infection Control in the Age of COVID-19 | Patient Interactions and Management | 2.25 | 5/1/2024 |
| The Radiographer: Patient Education and Communication | Patient Interactions and Management | 1.00 | 4/1/2024 |
| Patient-Centered Breast Imaging and Specialized Treatment | Patient Interactions and Management | 0.75 | 1/1/2024 |
| The Radiologic Technologist, Ethics, and Patient Advocacy: An Update | Patient Interactions and Management | 1.00 | 10/1/2023 |
| The Radiologic Technologist, Ethics, and Patient Advocacy: An Update | Radiation Physics, Radiobiology, and Regulations | 0.25 | 10/1/2023 |
| Ethical Issues in Breast Cancer Screening | Patient Interactions and Management | 0.25 | 9/1/2023 |
| Imaging Findings and Patient Management in HIV-Associated Malignancies | Endocrine and Oncology Procedures | 1.00 | 9/1/2023 |
| Breast Cancer: The Role of Functional Molecular Imaging | Endocrine and Oncology Procedures | 0.75 | 6/1/2023 |
| PET and PET/CT in the Diagnosis and Management of Follicular Lymphoma | Endocrine and Oncology Procedures | 1.00 | 4/1/2023 |
| The Role of Digital Radiography, Computed Tomography, Ultrasound, and Magnetic Resonance Imaging in the Diagnosis of Intimate Partner Violence | Patient Interactions and Management | 0.50 | 2/1/2023 |
| The Evolving Role of Magnetic Resonance Imaging in Parkinson’s Disease and Atypical Parkinsonism Disorders | Patient Interactions and Management | 0.50 | 1/1/2023 |
| Facing Addiction in America: The Surgeon General's Report on Alcohol, Drugs, and Health | Other Imaging Procedures | 1.50 | 11/1/2022 |
| Brachytherapy and Breast Cancer: Best Practices in Imaging-Based Patient Selection, Treatment Planning, and Future Trends | Patient Interactions and Management | 0.50 | 8/1/2022 |
| Radiation Exposure and Cancer Risk | Radiation Physics, Radiobiology, and Regulations | 1.00 | 8/1/2022 |
| Positron Emission Tomography in the Diagnosis and Treatment of Rheumatoid Arthritis | Other Imaging Procedures | 1.00 | 7/1/2022 |
| Three-Dimensional Digital Breast Tomosynthesis: An Update | Patient Interactions and Management | 0.50 | 7/1/2022 |
| Imaging Benign Breast Diseases: The Role of Sonography and Mammography | Endocrine and Oncology Procedures | 0.25 | 4/1/2022 |
| Imaging Benign Breast Diseases: The Role of Sonography and Mammography | Patient Interactions and Management | 0.50 | 4/1/2022 |
| Surgeon General's Workshop on Improving Health Literacy | Patient Interactions and Management | 3.00 | 3/1/2025 |
| The Role of Theranostics in Nuclear Medicine: Cancer Diagnosis and Management | Endocrine and Oncology Procedures | 1.00 | 12/1/2024 |
| Hepatobiliary Scintigraphy for the Diagnosis of Acute Cholecystitis | Gastrointestinal and Genitourinary Procedures | 1.00 | 7/1/2024 |
| The Role of Radiolabeled PET/CT in the Diagnosis and Characterization of Prostate Cancer | Endocrine and Oncology Procedures | 0.50 | 3/1/2024 |
| The Role of Radiolabeled PET/CT in the Diagnosis and Characterization of Prostate Cancer | Radionuclides and Radiopharmaceuticals | 0.50 | 3/1/2024 |
| Examining the Role of High-Resolution Breast PET in the Screening, Diagnosis, and Management of Breast Cancer | Endocrine and Oncology Procedures | 1.25 | 2/1/2024 |
| Imaging Insights in Alzheimer's Disease | Other Imaging Procedures | 0.50 | 12/1/2023 |
| Nuclear Medicine Dose Reduction: Wise and Gentle Imaging | Instrumentation | 0.50 | 9/1/2023 |
| Nuclear Medicine Dose Reduction: Wise and Gentle Imaging | Radiation Physics, Radiobiology, and Regulations | 0.50 | 9/1/2023 |
| Nuclear Medicine Dose Reduction: Wise and Gentle Imaging | Radionuclides and Radiopharmaceuticals | 0.25 | 9/1/2023 |
| Imaging and Ethical Considerations for Geriatric Patients | Patient Interactions and Management | 1.00 | 6/1/2023 |
| Lung Cancer: The Role of Nuclear Imaging With 18F-FDG PET/CT | Endocrine and Oncology Procedures | 0.50 | 12/1/2022 |
| Lung Cancer: The Role of Nuclear Imaging With 18F-FDG PET/CT | Instrumentation | 0.50 | 12/1/2022 |
| Informed Decision Making and Consent: Principles and Applications | Patient Interactions and Management | 1.00 | 11/1/2022 |
| Utilizing Gastrointestinal Sonography to Reduce Ionizing Radiation Within a Pediatric Population | Patient Interactions and Management | 0.50 | 10/1/2022 |
| Managing a Multigenerational Team of Imaging Professionals to Enhance Patient Care | Patient Interactions and Management | 1.25 | 10/1/2022 |
| PET/CT: Optimizing Imaging Protocols to Reduce Radiation Exposure | Instrumentation | 0.50 | 8/1/2022 |
| PET/CT: Optimizing Imaging Protocols to Reduce Radiation Exposure | Radiation Physics, Radiobiology, and Regulations | 0.50 | 8/1/2022 |
| Current Perspectives and Future Directions in PET and Treatment Planning for Breast Imaging | Endocrine and Oncology Procedures | 0.50 | 2/1/2022 |
| Radioimmunotherapy: A Review of I-131 Tositumomab and Y-90 Ibritumomab Tiuxetan for the Treatment of NHL | Endocrine and Oncology Procedures | 0.25 | 2/4/2022 |
| Radioimmunotherapy: A Review of I-131 Tositumomab and Y-90 Ibritumomab Tiuxetan for the Treatment of NHL | Radiation Physics, Radiobiology, and Regulations | 0.25 | 2/4/2022 |
| Radioimmunotherapy: A Review of I-131 Tositumomab and Y-90 Ibritumomab Tiuxetan for the Treatment of NHL | Radionuclides and Radiopharmaceuticals | 0.25 | 2/4/2022 |
| A Review of MRI of the Breast and MRI-Guided Stereotactic Biopsy | Patient Interactions and Management | 0.50 | 5/8/2022 |
| Screening for Breast Cancer: A New Approach | Patient Interactions and Management | 0.50 | 5/7/2022 |
| The Role of Image Fusion in Medical Dosimetry | Instrumentation | 1.00 | 5/7/2022 |
| The Role and Value of Nuclear Medicine in the Imaging of Sentinel Nodes and Breast Cancer | Endocrine and Oncology Procedures | 0.75 | 5/7/2022 |
| The Role and Value of Nuclear Medicine in the Imaging of Sentinel Nodes and Breast Cancer | Instrumentation | 0.25 | 5/7/2022 |
| Image-Guided Radiation Therapy for Breast Cancer | Patient Interactions and Management | 0.50 | 5/7/2022 |
| The Role of PET and PET/CT in the Diagnosis, Treatment Planning, and Post-Treatment Follow-up of HPV in Oropharyngeal and Anal Cancers | Endocrine and Oncology Procedures | 0.75 | 11/2/2022 |
| The Role of PET and PET/CT in the Diagnosis, Treatment Planning, and Post-Treatment Follow-up of HPV in Oropharyngeal and Anal Cancers | Instrumentation | 0.25 | 11/2/2022 |
| The Role of Neuroimaging in Diagnosis and Treatment of Adult Gliomas of the Brain | Endocrine and Oncology Procedures | 0.75 | 4/26/2022 |
| The Role of Neuroimaging in Diagnosis and Treatment of Adult Gliomas of the Brain | Patient Interactions and Management | 0.25 | 4/26/2022 |
| The Role of Imaging in Diagnosing and Managing the Treatment of Inflammatory Breast Cancer | Endocrine and Oncology Procedures | 0.25 | 11/6/2022 |
| The Role of Imaging in Diagnosing and Managing the Treatment of Inflammatory Breast Cancer | Patient Interactions and Management | 0.50 | 11/6/2022 |
984.227.8560Newsletter
Enter your email address to receive our new course alerts.